Short Interest Screener
Find squeeze candidates or browse the raw short-interest tape. Bi-weekly cadence — settlement dates typically lag by ~10 business days.
Screener results are algorithmic and for informational purposes only. Squeeze scores do not constitute trading recommendations. Short-interest data has an inherent ~2-week reporting lag. See Terms §17.
Mode
Matches
—
Symbols passing filters
Avg SI % Float
—
Across matched symbols
Avg Days-to-Cover
—
Across matched symbols
Avg 20d Return
—
Across matched symbols
Squeeze Rank
| Symbol | Name | Score ↕ | SI % Float | Δ SI % | DTC | SI Shares | Market Cap | SV % | 20d Return | 5d Return | Price | Settlement | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAE | CAE INC | 97357.57 | 13121.1% | +2395.9pp | 7.7 | 5,453,386 | $7.9B | 7181.0% | -2.0% | -2.0% | $24.43 | 2026-06-30 | |
| ZBIO | Zenas BioPharma, Inc. Common Stock | 1038.17 | 53.8% | +4.7pp | 9.6 | 12,196,436 | $1.9B | 5712.0% | 55.6% | 12.4% | $32.36 | 2026-06-30 | |
| SION | Sionna Therapeutics, Inc. Common Stock | 968.86 | 66.7% | +6.4pp | 10.1 | 5,522,307 | $2.1B | 6802.0% | 21.6% | 10.8% | $47.21 | 2026-06-30 | |
| WRAP | Wrap Technologies, Inc. Common Stock | 841.4 | 21.0% | -0.0pp | 29.9 | 5,762,534 | $104M | 3894.0% | 54.1% | -14.2% | $1.88 | 2026-06-30 | |
| IBTA | Ibotta, Inc. | 685.58 | 44.0% | +1.4pp | 17.4 | 3,046,287 | $752M | 2830.0% | -5.3% | -4.6% | $29.05 | 2026-06-30 | |
| ORIC | Oric Pharmaceuticals, Inc. Common Stock | 668.27 | 38.1% | +1.8pp | 12.3 | 22,108,499 | $1.1B | 4355.0% | 21.3% | 2.7% | $10.83 | 2026-06-30 | |
| GRPN | Groupon, Inc.Common Stock | 661.54 | 54.1% | -2.2pp | 6.1 | 11,957,442 | $1.1B | 5833.0% | 54.1% | 1.8% | $26.05 | 2026-06-30 | |
| NGNE | Neurogene, Inc. Common Stock | 591.42 | 34.4% | -2.0pp | 13.5 | 3,352,320 | $745M | 8409.0% | 13.7% | -6.1% | $36.68 | 2026-06-30 | |
| FRMM | Forum Markets, Incorporated Common Stock | 570.92 | 36.5% | -3.5pp | 11.4 | 3,092,951 | $80M | 4794.0% | 18.8% | -9.9% | $6.13 | 2026-06-30 | |
| MPT | Medical Properties Trust, Inc. | 554.23 | 27.9% | +1.3pp | 16.9 | 138,111,712 | $2.8B | 6551.0% | 8.7% | 5.6% | $4.87 | 2026-06-30 | |
| DMAC | DiaMedica Therapeutics Inc. Common Stock | 533.33 | 21.4% | +1.4pp | 17.7 | 5,206,327 | $378M | 3346.0% | 20.2% | -4.7% | $7.08 | 2026-06-30 | |
| TRP | TC Energy Corporation | 516.61 | 48.5% | +14.2pp | 10.6 | 32,403,545 | $71.4B | 3182.0% | 0.4% | 0.2% | $68.67 | 2026-06-30 | |
| GLUE | Monte Rosa Therapeutics, Inc. Common Stock | 491.22 | 37.8% | +3.0pp | 8.5 | 18,634,735 | $2.0B | 7269.0% | 26.6% | 0.7% | $23.63 | 2026-06-30 | |
| LENZ | LENZ Therapeutics, Inc. Common Stock | 487.17 | 57.1% | +0.3pp | 11.0 | 10,433,083 | $156M | 4791.0% | -11.3% | 4.7% | $5.16 | 2026-06-30 | |
| MPW | Medical Properties Trust, Inc. | 474.49 | 30.3% | -0.1pp | 24.1 | 150,604,080 | $3.0B | 6364.0% | -10.9% | -0.4% | $5.00 | 2026-01-30 | |
| LOVE | The Lovesac Company Common Stock | 469.19 | 25.1% | +0.7pp | 12.3 | 3,324,158 | $258M | 8522.0% | 25.6% | 0.3% | $17.59 | 2026-06-30 | |
| KOD | Kodiak Sciences Inc Common Stock | 460.7 | 34.1% | +0.5pp | 10.3 | 10,628,588 | $2.6B | 7001.0% | 15.8% | -1.9% | $42.42 | 2026-06-30 | |
| GPGI | GPGI, Inc. | 452.25 | 26.1% | -2.2pp | 16.5 | 33,119,039 | $4.2B | 8012.0% | 2.5% | 0.3% | $14.70 | 2026-06-30 | |
| TYRA | Tyra Biosciences, Inc. Common Stock | 442.97 | 42.5% | +7.3pp | 9.4 | 11,924,900 | $1.8B | 6858.0% | 5.7% | -3.1% | $31.85 | 2026-06-30 | |
| FLWS | 1-800-FLOWERS.COM Inc | 435.77 | 26.8% | -0.7pp | 11.9 | 7,985,650 | $271M | 6072.0% | 18.3% | 9.1% | $4.20 | 2026-06-30 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 432.22 | 26.8% | +1.3pp | 12.4 | 18,819,891 | $1.2B | 5881.0% | 15.2% | -3.3% | $14.47 | 2026-06-30 | |
| CHH | Choice Hotels Intnl. | 427.92 | 36.8% | +1.7pp | 12.0 | 7,724,097 | $5.0B | 4029.0% | -1.6% | -0.2% | $108.13 | 2026-06-30 | |
| PRME | Prime Medicine, Inc. Common Stock | 385.71 | 49.7% | +3.1pp | 9.1 | 34,729,797 | $551M | 6334.0% | -7.4% | -10.1% | $3.12 | 2026-06-30 | |
| IBRX | ImmunityBio, Inc. Common Stock | 383.11 | 35.8% | -0.9pp | 8.7 | 131,830,884 | $7.8B | 6551.0% | 11.8% | 2.4% | $8.07 | 2026-06-30 | |
| CHRS | Coherus Oncology, Inc. Common Stock | 380.36 | 19.3% | +0.3pp | 21.9 | 25,975,163 | $219M | 4915.0% | -0.7% | 1.4% | $1.47 | 2026-06-30 | |
| ORGO | Organogenesis Holdings Inc. Class A Common Stock | 377.55 | 19.2% | +2.1pp | 16.3 | 13,803,202 | $338M | 4102.0% | 10.3% | 14.5% | $2.68 | 2026-06-30 | |
| VSTM | Verastem, Inc. | 373.49 | 29.5% | +2.9pp | 7.0 | 24,142,937 | $505M | 5975.0% | 41.2% | 7.7% | $6.00 | 2026-06-30 | |
| HRTX | Heron Therapeutics, Inc. | 371.41 | 27.2% | -0.9pp | 11.1 | 40,499,859 | $91M | 4644.0% | 11.3% | 11.0% | $0.48 | 2026-06-30 | |
| RHI | Robert Half Inc. | 370.86 | 22.6% | -1.7pp | 9.0 | 22,306,015 | $4.3B | 5445.0% | 41.4% | 15.5% | $41.16 | 2026-06-30 | |
| BMEA | Biomea Fusion, Inc. Common Stock | 360.75 | 21.3% | -0.2pp | 14.6 | 13,830,845 | $95M | 4951.0% | 8.1% | 3.1% | $1.33 | 2026-06-30 | |
| TECX | Tectonic Therapeutic, Inc. Common Stock | 359.78 | 21.6% | -0.2pp | 14.3 | 2,136,671 | $605M | 5716.0% | 8.1% | -5.8% | $32.80 | 2026-06-30 | |
| PHAT | Phathom Pharmaceuticals, Inc. Common Stock | 356.46 | 27.6% | +1.9pp | 11.7 | 11,993,590 | $849M | 6005.0% | 5.2% | 1.9% | $11.25 | 2026-06-30 | |
| KIRK | Kirkland's Inc | 352.49 | 24.0% | -2.6pp | 15.0 | 1,628,433 | $37M | 5867.0% | -0.9% | -10.8% | $1.07 | 2025-07-15 | |
| AMCX | AMC Global Media Inc. Class A Common Stock | 341.45 | 23.2% | -0.0pp | 12.0 | 6,850,311 | $462M | 5410.0% | 11.6% | 6.2% | $10.43 | 2026-06-30 | |
| CMPX | Compass Therapeutics, Inc. Common Stock | 341.36 | 38.4% | +4.8pp | 8.9 | 37,138,819 | $364M | 5602.0% | 0.0% | -4.1% | $2.10 | 2026-06-30 | |
| ALT | Altimmune, Inc. Common Stock | 341.17 | 45.7% | +5.5pp | 8.1 | 47,634,141 | $546M | 6284.0% | -3.8% | -3.8% | $2.82 | 2026-06-30 | |
| CTXR | Citius Pharmaceuticals Inc. Common | 335.18 | 18.3% | -0.5pp | 23.4 | 4,763,787 | $13M | 5020.0% | -4.2% | 2.5% | $0.55 | 2026-06-30 | |
| GRAL | GRAIL, Inc. Common Stock | 331.59 | 22.3% | +1.9pp | 11.1 | 7,752,422 | $3.0B | 7731.0% | 17.1% | -0.6% | $72.71 | 2026-06-30 | |
| RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | 330.55 | 42.0% | -2.9pp | 8.4 | 172,302,180 | $1.5B | 6184.0% | -3.1% | -7.8% | $3.08 | 2026-06-30 | |
| FOUR | Shift4 Payments, Inc. | 329.44 | 28.5% | -1.7pp | 7.5 | 15,744,090 | $4.0B | 6317.0% | 27.3% | -1.8% | $49.11 | 2026-06-30 | |
| RLAY | Relay Therapeutics, Inc. Common Stock | 329.43 | 36.9% | +4.2pp | 7.2 | 43,041,464 | $4.2B | 7131.0% | 11.7% | 1.2% | $19.30 | 2026-06-30 | |
| SVRA | Savara Inc. | 326.41 | 24.5% | +0.5pp | 12.6 | 32,028,140 | $1.1B | 5436.0% | 2.6% | 2.6% | $5.84 | 2026-06-30 | |
| INBX | Inhibrx Biosciences, Inc. Common Stock | 322.76 | 37.1% | +1.6pp | 9.9 | 3,447,032 | $1.2B | 8735.0% | -6.1% | -6.0% | $87.61 | 2026-06-30 | |
| FDMT | 4D Molecular Therapeutics, Inc. Common Stock | 321.75 | 29.9% | +0.8pp | 9.1 | 13,305,097 | $580M | 7565.0% | 9.2% | -2.8% | $11.38 | 2026-06-30 | |
| ABEO | Abeona Therapeutics Inc. Common Stock | 318.29 | 28.9% | -1.0pp | 8.7 | 13,680,180 | $369M | 7521.0% | 13.6% | -7.5% | $6.53 | 2026-06-30 | |
| IOVA | Iovance Biotherapeutics, Inc. Common Stock | 317.04 | 26.3% | -0.8pp | 7.1 | 100,526,623 | $2.2B | 5203.0% | 35.0% | 39.4% | $5.48 | 2026-06-30 | |
| TRIP | TripAdvisor, Inc. | 314.45 | 30.9% | -1.2pp | 8.3 | 33,000,280 | $1.7B | 6961.0% | 11.7% | -1.4% | $13.80 | 2026-06-30 | |
| NTST | NetSTREIT Corp. | 313.95 | 34.5% | +0.6pp | 7.2 | 33,352,605 | $2.1B | 3407.0% | 12.9% | 2.4% | $21.92 | 2026-06-30 | |
| MDWD | MediWound Ltd. | 312.48 | 17.0% | -0.6pp | 17.6 | 1,630,683 | $188M | 3544.0% | 2.3% | 0.2% | $14.28 | 2026-06-30 | |
| ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | 303.54 | 29.9% | +0.4pp | 15.5 | 6,801,943 | $170M | 6537.0% | -17.2% | -6.0% | $5.99 | 2026-06-30 |
Reading This Screener
Two Modes
- Squeeze Rank: Composite score =
SI %-of-float × min(DTC, 20) × momentum multiplier. Momentum multiplier ranges 0.5x–2x based on the 20-day return — positive returns amplify the score because shorts are already bleeding. Best signal when the "Require +20d return" filter is on. - Data Browser: The unopinionated table sorted by SI %-of-float. Turn off "Require +20d return" and set Min DTC to 0.5 for the widest view.
The Fields
- SI %-of-Float: Short shares divided by free float. Anything over 20% is aggressive; over 30% is squeeze territory.
- Δ SI %: Change since the prior report (~2 weeks earlier). Rising = more shorts piling on; falling = covering.
- DTC (Days-to-Cover): Short shares divided by average daily volume. Higher = harder to close positions without moving price.
- SV % (Short Volume %): From the daily consolidated tape — how much of today's volume was short-side. Updated daily, unlike SI which is bi-weekly.
- 20d Return: Positive return on a high-SI name = short book is already under water. That's fuel.
Data Cadence
Short interest is published twice a month with a ~10-business-day lag. The daily "SV %" column is a much fresher proxy for short-side conviction. Free-float is refreshed from public issuer filings when they change.